La Jolla Pharmaceutical Company Announces Fourth-Quarter And Full-Year 2013 Financial Results And Highlights Recent Corporate Progress
Published: Apr 01, 2014
La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the “Company” or “La Jolla”), a leader in the development of therapeutics targeting significant unmet life-threatening diseases, announces fourth-quarter and full-year 2014 financial results and highlights recent corporate progress.
Help employers find you! Check out all the jobs and post your resume.